Details

Autor(en) / Beteiligte

• Igarashi, Yuka
• Uchiyama, Toru
• Minegishi, Tomoko
• Takahashi, Sirirat
• Watanabe, Nobuyuki
• Kawai, Toshinao
• Yamada, Masafumi
• Ariga, Tadashi
• Onodera, Masafumi

Titel

Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy

Ist Teil von

• Molecular therapy. Methods & clinical development, 2017-09, Vol.6 (C), p.8-16

Ort / Verlag

United States: Elsevier Limited

Erscheinungsjahr

2017

Quelle

Open access e-journals

Beschreibungen/Notizen

• Clinical improvement in stem cell gene therapy (SCGT) for primary immunodeficiencies depends on the engraftment levels of genetically corrected cells, and tracing the transgene in each hematopoietic lineage is therefore extremely important in evaluating the efficacy of SCGT. We established a single cell-based droplet digital PCR (sc-ddPCR) method consisting of the encapsulation of a single cell into each droplet, followed by emulsion PCR with primers and probes specific for the transgene. A fluorescent signal in a droplet indicates the presence of a single cell carrying the target gene in its genome, and this system can clearly determine the ratio of transgene-positive cells in the entire population at the genomic level. Using sc-ddPCR, we analyzed the engraftment of vector-transduced cells in two patients with severe combined immunodeficiency (SCID) who were treated with SCGT. Sufficient engraftment of the transduced cells was limited to the T cell lineage in peripheral blood (PB), and a small percentage of CD34 cells exhibited vector integration in bone marrow, indicating that the transgene-positive cells in PB might have differentiated from a small population of stem cells or lineage-restricted precursor cells. sc-ddPCR is a simplified and powerful tool for the detailed assessment of transgene-positive cell distribution in patients treated with SCGT.